Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLXPF | VYGR | ABSI | ||
Company | Cybin Inc | Voyager Therapeut | Absci Corp | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 3.0500 | 8.43 | 4.00 | ||
High | 3.2000 | 8.83 | 4.11 | ||
Low | 2.8736 | 8.27 | 3.76 | ||
Last | 3.0200 | 8.77 | 4.10 | ||
Change | -0.0400 | +0.40 | +0.13 | ||
% Change | -1.31% | +4.78% | +3.27% | ||
Volume | 864,300 | 342,500 | 1,075,200 | ||
20-Day Average Volume | 1,094,590 | 498,740 | 2,298,955 | ||
Previous Close | 3.0600 | 8.37 | 3.97 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.8482 | 8.20 | 3.55 | ||
20-Day Raw Stochastic | 71.64% | 68.22% | 72.73% | ||
20-Day Relative Strength | 62.45% | 55.27% | 52.73% | ||
Weighted Alpha | +130.72 | +2.18 | +53.85 | ||
Today's Opinion | N/A | 40% Buy | 8% Sell | ||
Previous Opinion | N/A | 8% Buy | 24% Sell | ||
Last Month's Opinion | N/A | 24% Sell | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +11.46% since 07/28/21 | -2.12% since 07/15/24 | +3.80% since 07/15/24 | ||
Low | 2.7300 on 07/29/21 | 8.27 on 07/22/24 | 3.76 on 07/22/24 | ||
High | 3.3800 on 08/02/21 | 9.24 on 07/16/24 | 4.55 on 07/16/24 | ||
1-Month | |||||
%Chg | +42.45% since 07/02/21 | +8.41% since 06/21/24 | +35.76% since 06/21/24 | ||
Low | 2.1105 on 07/08/21 | 7.31 on 07/05/24 | 2.90 on 06/26/24 | ||
High | 3.3800 on 08/02/21 | 9.45 on 07/12/24 | 4.55 on 07/16/24 | ||
3-Month | |||||
%Chg | +79.76% since 05/04/21 | +15.85% since 04/22/24 | -9.09% since 04/22/24 | ||
Low | 1.3429 on 06/01/21 | 7.26 on 04/25/24 | 2.80 on 06/20/24 | ||
High | 3.3800 on 08/02/21 | 9.45 on 07/12/24 | 5.44 on 05/03/24 | ||
6-Month | |||||
%Chg | +76.61% since 02/04/21 | +16.16% since 01/22/24 | +13.42% since 01/22/24 | ||
Low | 0.9500 on 03/30/21 | 7.08 on 02/13/24 | 2.80 on 06/20/24 | ||
High | 3.3800 on 08/02/21 | 10.66 on 04/01/24 | 6.72 on 04/09/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 453,224 | 455,278 | 448,943 | ||
Shares Outstanding, K | 148,598 | 54,394 | 113,084 | ||
Annual Sales | 650,000 | 250,010,000 | 5,720,000 | ||
Annual Net Income | -24,420,000 | 132,330,000 | -110,570,000 | ||
Last Quarter Sales | N/A | 19,520,000 | 900,000 | ||
Last Quarter Net Income | N/A | -11,330,000 | -21,980,000 | ||
60-Month Beta | N/A | 0.96 | 2.20 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.20 on 05/13/24 | -0.22 on 05/14/24 | ||
Latest Earnings Date | N/A | 08/01/24 | 08/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |